Antiseptic Skin Cleanser

Manufacturer: Kinray Inc. | Xttrium Laboratories, Inc.
Effective date: 2013-08-01
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-02 01:40:08

Label at a glance#

ProductAntiseptic Skin Cleanser

Active ingredientCHLORHEXIDINE GLUCONATE

Label structure9 sections

Indications and uses

Healthcare Professional handwash : helps reduce bacteria that potentially can cause disease.. Patient preoperative skin preparation: for the preparation of the patient's skin prior to surgery Skin wound and genral skin cleaning

Dosage and administration

use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns. Healthcare personnel handwash: wet hands with water dispense about 5ml of product into cupped hands and wahs in vigorous manner for about 15 seconds rinse and dry thoroughly Patient preoperative skin preparation: apply product librally to surgical site and swab for at least 2 minutes and dry ...

Storage and handling

store at 20°-25° C (68°-77° F) avoid excessive heat above 40° C (104° F)

Contacts and useful links#

PhoneLabel contact1-800-587-3721

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Chlorhexidine Gluconate 4% Solution

Purpose

OTC - PURPOSE SECTION

Antiseptic

Uses

INDICATIONS & USAGE SECTION

Healthcare Professional handwash: helps reduce bacteria that potentially can cause disease..

Patient preoperative skin preparation: for the preparation of the patient's skin prior to surgery

Skin wound and genral skin cleaning

Warnings

WARNINGS SECTION

for external use only

Do not use

OTC - DO NOT USE SECTION

if you are alleric to chlorhexidine gluconate or any ohter ingredient
in contact with meninges
in genital area
as a preoperative skin preparation of the head or face

When using this product

OTC - WHEN USING SECTION

keep out of eyes, ears, an mouth. Maycause seriously and permanent eye injury if placed or kept in the eye during surgical procedures or may cause deafness when installed in the middle ear thru perforated eardurms.
if solution should contact these areas, rinse out promptly and thoroughly with water
wounds which involve more than the superficial layers of the skin should not be routinely treated
repeated general skin cleansing of large body areas should not be done except when the underlying condition makes it necessary to reduce the bacterial population of skin

Stop use and ask doctor if

OTC - STOP USE SECTION

irritation, sensitization, or allergic reaction occurs. These may be signs of a serious condition.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control center right away

Warning

USER SAFETY WARNINGS SECTION

This product contains a chemical known to the State of California to cause Cancer.

Directions

DOSAGE & ADMINISTRATION SECTION

use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns.

Healthcare personnel handwash:

wet hands with water
dispense about 5ml of product into cupped hands and wahs in vigorous manner for about 15 seconds
rinse and dry thoroughly

Patient preoperative skin preparation:

apply product librally to surgical site and swab for at least 2 minutes and dry with a sterile towel
repeat procedure for an additional 2 minutes and dry with a sterile towel

Skin wound and normal skin cleansing:

thoroughly rinse the area to be cleaned with water
apply the minimum amount of product necessary to cover the skin or wound area and wash gently
rinse again thoroughly

Other information

STORAGE AND HANDLING SECTION

store at 20°-25° C (68°-77° F)
avoid excessive heat above 40° C (104° F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

cocamide DEA, fragrance, glucono-delta-lactone, isopropyl alcohol, lauramine oxide, PEG-75 lanolin, purified water, tridecyl alcohol

Questions of comments?

OTC - QUESTIONS SECTION

call 1-800-587-3721 Monday through Friday 8 AM to 4:30 PM CST

Package label and principal display panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Preferred Plus Pharmacy

NDC 61715-072-08

Antiseptic Skin Cleanser

(Chlorhexidine Gluconate 4% solution)

Antiseptic/Antimicrobial Skin Cleanser

for external use only

8FL OZ. (237 mL)

Do no use if seal is broken or missing

Prinicipal diplay panelinformation display panel 1

information display panel 2information display panel 3

information display panel 4

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61715-072-08	2025-06-02	C162847	48780-1	9d75b9d0-131b-f424-e053-dadaa90a57ce	Drug Facts
61715-072-08	2020-01-31	C162847	48780-1	9d75b9d0-131b-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61715-072	ANTISEPTIC SKIN CLEANSER (CHLORHEXIDINE GLUCONATE 4%) LIQUID [KINRAY INC.]	2	Legacy NDC	20130803_dfdaa646-0ef5-4433-b8d3-39ec139827b9.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CHLORHEXIDINE GLUCONATE	ACTIVE INGREDIENT	MOR84MUD8E	2
CHLORHEXIDINE	ACTIVE MOIETY	R4KO0DY52L	2
COCO DIETHANOLAMIDE	INACTIVE INGREDIENT	92005F972D	2
GLUCONOLACTONE	INACTIVE INGREDIENT	WQ29KQ9POT	2
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	INACTIVE INGREDIENT	S38J6RZN16	2
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	2
PEG-75 LANOLIN	INACTIVE INGREDIENT	09179OX7TB	2
TRIDECYL ALCOHOL	INACTIVE INGREDIENT	8I9428H868	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Antiseptic Skin Cleanser
Chlorhexidine Gluconate 4%
CHLORHEXIDINE GLUCONATE
CHLORHEXIDINE
COCO DIETHANOLAMIDE
PEG-75 LANOLIN
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)
ISOPROPYL ALCOHOL
WATER
TRIDECYL ALCOHOL
GLUCONOLACTONE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
61715-072	61715-072-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CHLORHEXIDINE GLUCONATE	MOR84MUD8E	ACTIB
COCO DIETHANOLAMIDE	92005F972D	IACT
PEG-75 LANOLIN	09179OX7TB	IACT
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	S38J6RZN16	IACT
ISOPROPYL ALCOHOL	ND2M416302	IACT
WATER	059QF0KO0R	IACT
TRIDECYL ALCOHOL	8I9428H868	IACT
GLUCONOLACTONE	WQ29KQ9POT	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 38 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	SPONGE / TOPICAL	4 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SOLUTION / ORAL		3 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
GLUCONOLACTONE	GLUCONOLACTONE	WQ29KQ9POT	INJECTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 6 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	GEL / TOPICAL		4 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	TABLET, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 9 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SUSPENSION / AURICULAR (OTIC)		1 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	GEL, METERED / TOPICAL		525 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
COCO DIETHANOLAMIDE	COCO DIETHANOLAMIDE	92005F972D	SOLUTION / TOPICAL	2.5 %w/v		Exact identifier — unii candidate 5 equally ranked IID candidates
COCO DIETHANOLAMIDE	COCO DIETHANOLAMIDE	92005F972D	SHAMPOO / TOPICAL		600 mg	Exact identifier — unii candidate 5 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SOLUTION / OPHTHALMIC	0.5 %w/v		Exact identifier — unii candidate 15 equally ranked IID candidates
GLUCONOLACTONE	GLUCONOLACTONE	WQ29KQ9POT	CLOTH / TOPICAL	NA		Exact identifier — unii candidate 6 equally ranked IID candidates
COCO DIETHANOLAMIDE	COCO DIETHANOLAMIDE	92005F972D	SPONGE / TOPICAL	2 %w/w		Exact identifier — unii candidate 5 equally ranked IID candidates
GLUCONOLACTONE	GLUCONOLACTONE	WQ29KQ9POT	SOLUTION / TOPICAL	0.3 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
GLUCONOLACTONE	GLUCONOLACTONE	WQ29KQ9POT	SPONGE / TOPICAL	ADJ PH		Exact identifier — unii candidate 6 equally ranked IID candidates
COCO DIETHANOLAMIDE	COCO DIETHANOLAMIDE	92005F972D	CREAM / TOPICAL		30 mg	Exact identifier — unii candidate 5 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SPRAY / NASAL	0.1 mg/0.2ml		Exact identifier — unii candidate 15 equally ranked IID candidates
PEG-75 LANOLIN	PEG-75 LANOLIN	09179OX7TB	EMULSION / TOPICAL	1.5 %w/w		Exact identifier — unii candidate 3 equally ranked IID candidates
PEG-75 LANOLIN	PEG-75 LANOLIN	09179OX7TB	AEROSOL / TOPICAL	1.5 %w/w		Exact identifier — unii candidate 3 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	TABLET, CHEWABLE / ORAL	5.9 mg		Exact identifier — unii candidate 15 equally ranked IID candidates
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	SWAB / TOPICAL	43.9 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SYRUP / ORAL	2 mg/5ml		Exact identifier — unii candidate 15 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SOLUTION/ DROPS / OPHTHALMIC	0.5 %w/v		Exact identifier — unii candidate 15 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	TABLET, EXTENDED RELEASE / ORAL		350 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	LOTION / TOPICAL	0.2 %w/v		Exact identifier — unii candidate 15 equally ranked IID candidates
COCO DIETHANOLAMIDE	COCO DIETHANOLAMIDE	92005F972D	SUSPENSION / TOPICAL	4 %w/w		Exact identifier — unii candidate 5 equally ranked IID candidates
GLUCONOLACTONE	GLUCONOLACTONE	WQ29KQ9POT	INJECTION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 6 equally ranked IID candidates
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	OIL / AURICULAR (OTIC)		6 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SOLUTION / TOPICAL	0.21 %w/v		Exact identifier — unii candidate 15 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	POWDER, FOR SUSPENSION / ORAL		560 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
GLUCONOLACTONE	GLUCONOLACTONE	WQ29KQ9POT	ELIXIR / ORAL	NA		Exact identifier — unii candidate 6 equally ranked IID candidates
PEG-75 LANOLIN	PEG-75 LANOLIN	09179OX7TB	SOLUTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 3 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SUSPENSION / OPHTHALMIC	0.25 %w/v		Exact identifier — unii candidate 15 equally ranked IID candidates
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	GEL / TOPICAL		75 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SUSPENSION / ORAL		100 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	OIL / TOPICAL		72 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	LOTION, AUGMENTED / TOPICAL		2070 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)	HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	S38J6RZN16	SUSPENSION / TOPICAL	0.69 %w/v		Exact identifier — unii candidate 15 equally ranked IID candidates
ISOPROPYL ALCOHOL	ISOPROPYL ALCOHOL	ND2M416302	SOLUTION / TOPICAL	40 %w/v		Exact identifier — unii candidate 9 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N019125-001	DYNA-HEX 4	CHLORHEXIDINE GLUCONATE	4%	SOLUTION / TOPICAL			1984-12-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N019125-001	DYNA-HEX 4	4%	SOLUTION / TOPICAL	1984-12-24	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N019125-001	DYNA-HEX 4	4%	SOLUTION / TOPICAL	1984-12-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N019125-001	EXIDINE	4%	SOLUTION / TOPICAL	1984-12-24	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
36de642e-55bf-4a0a-8ade-e55207e3ca1d			dfdaa646-0ef5-4433-b8d3-39ec139827b9	2025-05-28	Warnings	Exact identifier spl set id: dfdaa646-0ef5-4433-b8d3-39ec139827b9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.